Although feedback between these pathways has been proposed as a mechanism for resistance to MEK- or PI3K-targeted treatment strategies [27], combined targeting of MAPK and PI3K was still insufficient to induce AML cell death. The gene discussed is MAP2K7; the disease is acute myeloid leukemia.